The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Modeling pulmonary fibrosis with bleomycin
Abstract
PURPOSE OF REVIEW: Idiopathic pulmonary fibrosis is a chronic pulmonary disease of unknown origin ultimately leading to death. No treatment exists yet and animal models have been employed in order to elucidate its etiopathogenesis. Here, we summarize the characteristics of the bleomycin animal model, the most commonly used model of pulmonary fibrosis, highlighting recent advances it has led us to despite its disadvantages. RECENT FINDINGS: Repetitive intratracheal administration of bleomycin more effectively mimics the chronic aspect of pulmonary fibrosis, as well as other characteristics including the presence of hyperplastic alveolar epithelial cells. Epithelial-to-mesenchymal transition seems to be a major contributor to the lung fibroblast population. There is growing evidence that macrophages, as well as fibrocytes, are largely involved in disease progression by mediating fibroblast and myofibroblast activation. In addition, molecules involved in phospholipid homeostasis are now becoming more appealing as potential therapeutic targets. SUMMARY: Despite its disadvantages, the bleomycin animal model remains the best available experimental tool for studying disease pathogenesis and testing of novel pharmaceutical compounds. Two such compounds currently showing some promise in clinical trials have emerged through the bleomycin model and preliminary results of basic research using this model have shown that more candidate compounds may follow in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935
Tager, A. M., LaCamera, P., Shea, B. S., Campanella, G. S., Selman, M., Zhao, Z., Polosukhin, V., Wain, J., Karimi-Shah, B. A., Kim, N. D., et al. (2008) · Nature Medicine · doi:10.1038/nm1685 · Cited by 823
Murine models of pulmonary fibrosis
Moore, B. B., & Hogaboam, C. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2007 · Cited by 796
Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
Pandit, K. V., Corcoran, D., Yousef, H., Yarlagadda, M., Tzouvelekis, A., Gibson, K. F., Konishi, K., Yousem, S. A., Singh, M., Handley, D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200911-1698oc · Cited by 506
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed Central · Cited by 479
Two pathways for lysophosphatidic acid production
AOKI, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.06.005 · Cited by 448
The mouse ascending: perspectives for human-disease models
Rosenthal, N., & Brown, S. (2007) · Nature Cell Biology · doi:10.1038/ncb437 · Cited by 442
Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.046 · Cited by 436
Meltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Tanjore, H., Xu, X. C., Polosukhin, V. V., Degryse, A. L., Li, B., Han, W., Sherrill, T. P., Plieth, D., Neilson, E. G., Blackwell, T. S., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0322oc · Cited by 405
Kim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.013 · Cited by 362
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
Pechkovsky, D. V., Prasse, A., Kollert, F., Engel, K. M. Y., Dentler, J., Luttmann, W., Friedrich, K., Müller-Quernheim, J., & Zissel, G. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.017 · Cited by 328
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., McMahon, F. B., Gleaves, L. A., Blackwell, T. S., & Lawson, W. E. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00026.2010 · Cited by 311
MicroRNAs in idiopathic pulmonary fibrosis
Pandit, K. V., Milosevic, J., & Kaminski, N. (2011) · Translational Research · doi:10.1016/j.trsl.2011.01.012 · Cited by 311
Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients
YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-6-861 · Cited by 286
Production of Interleukin 13 by Alveolar Macrophages from Normal and Fibrotic Lung
Hancock, A., Armstrong, L., Gama, R., & Millar, A. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.1.2627 · Cited by 275
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
A novel, orally active LPA 1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
Swaney, J., Chapman, C., Correa, L., Stebbins, K., Bundey, R., Prodanovich, P., Fagan, P., Baccei, C., Santini, A., Hutchinson, J., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00828.x · Cited by 261
Strategies for treating idiopathic pulmonary fibrosis
du Bois, R. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2958 · Cited by 251
The mechanism of the bleomycin-induced cleavage of DNA
William Lown, J., & Sim, S.-K. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(77)80099-5 · Cited by 248
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 240
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230
Murray, L. A., Rosada, R., Moreira, A. P., Joshi, A., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Mathai, S., Gulati, M., Herzog, E. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009683 · Cited by 192
Oga, T., Matsuoka, T., Yao, C., Nonomura, K., Kitaoka, S., Sakata, D., Kita, Y., Tanizawa, K., Taguchi, Y., Chin, K., et al. (2009) · Nature Medicine · doi:10.1038/nm.2066 · Cited by 190
Umezawa, H., Ishizuka, M., Maeda, K., & Takeuchi, T. (1967) · Cancer · doi:10.1002/1097-0142(1967)20:5<891::aid-cncr2820200550>3.0.co;2-v · Cited by 189
Manoury, B., Nenan, S., Leclerc, O., Guenon, I., Boichot, E., Planquois, J.-M., Bertrand, C. P., & Lagente, V. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-11 · Cited by 186
Aguilar, S., Scotton, C. J., McNulty, K., Nye, E., Stamp, G., Laurent, G., Bonnet, D., & Janes, S. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008013 · Cited by 171
Liu, T., Jin, H., Ullenbruch, M., Hu, B., Hashimoto, N., Moore, B., McKenzie, A., Lukacs, N. W., & Phan, S. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3425 · Cited by 167
Jun, D., Garat, C., West, J. D., Thorn, N., Chow, K. S., Cleaver, T. G., Sullivan, T., Torchia, E. C., Childs, C. R., Shade, T. R., et al. (2011) · Stem Cells · doi:10.1002/stem.604 · Cited by 164
A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis
Nagase, T., Uozumi, N., Ishii, S., Kita, Y., Yamamoto, H., Ohga, E., Ouchi, Y., & Shimizu, T. (2002) · Nature Medicine · doi:10.1038/nm0502-480 · Cited by 163
Bocchino, M., Agnese, S., Fagone, E., Svegliati, S., Grieco, D., Vancheri, C., Gabrielli, A., Sanduzzi, A., & Avvedimento, E. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014003 · Cited by 157
Shea, B. S., Brooks, S. F., Fontaine, B. A., Chun, J. J. M., Luster, A. D., & Tager, A. M. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0345oc · Cited by 155
Ueno, M., Maeno, T., Nomura, M., Aoyagi, K., Matsui, H., Hara, K., Tanaka, T., Iso, T., Suga, T., & Kurabayashi, M. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2010 · Cited by 155
Kono, Y., Nishiuma, T., Nishimura, Y., Kotani, Y., Okada, T., Nakamura, S., & Yokoyama, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0065oc · Cited by 152
Swaney, J. S., Chapman, C. W., Correa, L. D., Stebbins, K. J., Broadhead, A. R., Bain, G., Santini, A. M., Darlington, J. V., King, C. D., Baccei, C. S., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175901 · Cited by 146
Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., Stoolman, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38369 · Cited by 144
Role of Repeated Lung Injury and Genetic Background in Bleomycin-Induced Fibrosis
Chung, M. P., Monick, M. M., Hamzeh, N. Y., Butler, N. S., Powers, L. S., & Hunninghake, G. W. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0029oc · Cited by 135
Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis
Senoo, T., Hattori, N., Tanimoto, T., Furonaka, M., Ishikawa, N., Fujitaka, K., Haruta, Y., Murai, H., Yokoyama, A., & Kohno, N. (2010) · Thorax · doi:10.1136/thx.2009.119974 · Cited by 135
Kim, T. H., Lee, Y. H., Kim, K. H., Lee, S. H., Cha, J. Y., Shin, E. K., Jung, S., Jang, A., Park, S., Uh, S. T., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0659oc · Cited by 120
IPF: new insight on pathogenesis and treatment
Harari, S. A., & Caminati, A. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02305.x · Cited by 119
Song, J. S., Kang, C. M., Kang, H. H., Yoon, H. K., Kim, Y. K., Kim, K. H., Moon, H. S., & Park, S. H. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.6.048 · Cited by 118
Sebti, S. M., Mignano, J. E., Jani, J. P., Srimatkandada, S., & Lazo, J. S. (1989) · Biochemistry · doi:10.1021/bi00442a003 · Cited by 103
Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial
the Ifigenia study group*, Behr, J., Demedts, M., Buhl, R., Costabel, U., Dekhuijzen, R. P. N., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., et al. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-101 · Cited by 102
Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells
Haudek, S. B., Trial, J., Xia, Y., Gupta, D., Pilling, D., & Entman, M. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804910105 · Cited by 89
The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.
Strieter, R. M., Keeley, E. C., Burdick, M. D., & Mehrad, B. (2009) · PubMed Central · Cited by 84
Markers of macrophage differentiation in experimental silicosis
Misson, P., van den Brûle, S., Barbarin, V., Lison, D., & Huaux, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104019 · Cited by 81
Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis
Tanaka, K., Ishihara, T., Azuma, A., Kudoh, S., Ebina, M., Nukiwa, T., Sugiyama, Y., Tasaka, Y., Namba, T., Ishihara, T., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00289.2009 · Cited by 72
Exposures and Idiopathic Lung Disease
Taskar, V. S., & Coultas, D. (2008) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0028-1101277 · Cited by 70
Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model
Wuyts, W. A., Willems, S., Vos, R., Vanaudenaerde, B. M., Vleeschauwer, S. I. D., Rinaldi, M., Vanhooren, H. M., Geudens, N., Verleden, S. E., Demedts, M., et al. (2010) · Experimental Lung Research · doi:10.3109/01902148.2010.492895 · Cited by 69
Selman, M., Rojas, M., Mora, A. L., & Pardo, A. (2010) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0030-1265901 · Cited by 67
Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells
Mungunsukh, O., Griffin, A. J., Lee, Y. H., & Day, R. M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00322.2009 · Cited by 65
Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis
Wang, L., Antonini, J. M., Rojanasakul, Y., Castranova, V., Scabilloni, J. F., & Mercer, R. R. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10220 · Cited by 64
Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis
Bitencourt, C. S., Pereira, P. A. T., Ramos, S. G., Sampaio, S. V., Arantes, E. C., Aronoff, D. M., & Faccioli, L. H. (2011) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-4-3 · Cited by 58
Effect of an immunotoxin to folate receptor β on bleomycin-induced experimental pulmonary fibrosis
Nagai, T., Tanaka, M., Hasui, K., Shirahama, H., Kitajima, S., Yonezawa, S., Xu, B., & Matsuyama, T. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04182.x · Cited by 45
Granata, F., Nardicchi, V., Loffredo, S., Frattini, A., Staiano, R. I., Agostini, C., & Triggiani, M. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.006 · Cited by 44
Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis
Azuma, A. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.32 · Cited by 44
Antoniou, K. M., Papadaki, H. Α., Soufla, G., Kastrinaki, M.-C., Damianaki, A., Koutala, H., Spandidos, D. A., & Siafakas, N. M. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.015 · Cited by 42
Patel, R. B., Kotha, S. R., Sherwani, S. I., Sliman, S. M., Gurney, T. O., Loar, B., Butler, S. O., Morris, A. J., Marsh, C. B., & Parinandi, N. L. (2010) · International Journal of Toxicology · doi:10.1177/1091581810388850 · Cited by 30
Expression of phospholipases A2 in primary human lung macrophages
Giannattasio, G., Lai, Y., Granata, F., Mounier, C. M., Nallan, L., Oslund, R., Leslie, C. C., Marone, G., Lambeau, G. J., Gelb, M. H., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.002 · Cited by 29
Niese, K. A., Chiaramonte, M. G., Ellies, L. G., Rothenberg, M. E., & Zimmermann, N. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-87 · Cited by 29
Cited by
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. S., & Perlman, H. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0086ma · Cited by 838
Diverse functions of matrix metalloproteinases during fibrosis
Giannandrea, M., & Parks, W. C. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012062 · Cited by 541
Inflammation and immunity in IPF pathogenesis and treatment
Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.12.015 · Cited by 517
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Della Latta, V., Cecchettini, A., Del Ry, S., & Morales, M. A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.012 · Cited by 514
Li, D., Guabiraba, R., Besnard, A.-G., Komai-Koma, M., Jabir, M. S., Zhang, L., Graham, G. J., Kurowska-Stolarska, M., Liew, F. Y., McSharry, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.011 · Cited by 413
Metadata
- Authors
- Mouratis, M. A., & Aidinis, V.
- Venue
- Current Opinion in Pulmonary Medicine
- Published
- 2011-09
- Volume
- 17
- Issue
- 5
- Pages
- 355-361
- ISSN
- 1070-5287 (ISSN-L)
- OpenAlex
- W2054017711
- Cited by
- 311
- References
- 68
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.